Trinity Biotech | TRIB - Gross Profit On Sales

Stock Price
0.60
Daily Change
-0.01 -2.12%
Monthly
6.57%
Yearly
-23.37%
Q2 Forecast
0.62

Trinity Biotech reported $6.47M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Bayer EUR 5.35B 1.02B Sep/2025
Bio-Rad Laboratories USD 343.4M 1.9M Sep/2025
EDAP TMS EUR 5.97M 850K Sep/2025
J&J USD 17.24B 642M Mar/2026
Mesa Laboratories USD 39.75M 4.3M Dec/2024
OraSure Technologies USD 11.34M 435K Dec/2025
Plus Therapeutics 1.37M 30K Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Siemens EUR 8.1B 567M Sep/2025
Surmodics USD 20.08M 31.62M Jun/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Tosoh JPY 67.57B 10.89B Sep/2025
Trinity Biotech USD 6.47M 1.59M Sep/2025
Veracyte USD 101.97M 10.69M Dec/2025